🇺🇸 FDA
Company

Phio

Phio Pharmaceuticals

PHIO pharma USA

Quick answer

Phio is a pharma company (PHIO) headquartered in KING OF PRUSSIA, PA, USA with 2 tracked pipeline programs.

Pipeline (2)

project

DP CD8 TIL

HNSCC

Phase 1 · mab · active

1 trials project

PH-762

Squamous Cell Carcinoma of the Skin

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 11926828

Methods for treating aging and skin disorders using nucleic acids targeting TYR

Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11639359

Bryoid compositions, methods of making and use thereof

Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11584933

RNA interference in ocular indications

Expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11396654

Neutral nanotransporters

Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11279934

Methods for treating cancer using nucleic acids targeting MDM2 or MYCN

Expires Mon Mar 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11254940

Inhibition of MAP4K4 through RNAi

Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11234932

Combination HIV therapeutic

Expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11118178

Reduced size self-delivering RNAI compounds

Expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)